If cell therapies based on somatic cell nuclear transfer (SCNT), so called therapeutic cloning, were more ethically acceptable and practical, this would be less of an issue because the cells would be genetically matched to the intended patient. This is one of the advantages of personalized treatments over off-the shelf therapies.
If cell therapies based on somatic cell nuclear transfer (SCNT), so called therapeutic cloning, were more ethically acceptable and practical, this would be less of an issue because the cells would be genetically matched to the intended patient. This is one of the advantages of personalized treatments over off-the shelf therapies.
If you are European Descent, higher chance of being eligible for HLA-A2:01 therapy as compared to overall population.
If you are Chinese, higher chance of being eligible for HLA-A11:01 as compared to overall population (and European descent lower chance)
Do you get the point?